메뉴 건너뛰기




Volumn 360, Issue 2, 2015, Pages 213-218

Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial

Author keywords

CirCe01; Circulating tumor cells; Metastatic breast cancer

Indexed keywords

ALBUMIN; LACTATE DEHYDROGENASE;

EID: 84924859018     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.02.010     Document Type: Article
Times cited : (43)

References (21)
  • 1
    • 4143094988 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression, and survival in metastatic breast cancer
    • Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med 2004, 351:781-791. 10.1056/NEJMoa040766.
    • (2004) N. Engl. J. Med , vol.351 , pp. 781-791
    • Cristofanilli, M.1    Budd, G.T.2    Ellis, M.J.3    Stopeck, A.4    Matera, J.5    Miller, M.C.6
  • 2
    • 20144385756 scopus 로고    scopus 로고
    • Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
    • Cristofanilli M., Hayes D.F., Budd G.T., Ellis M.J., Stopeck A., Reuben J.M., et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol 2005, 23:1420-1430. 10.1200/JCO.2005.08.140.
    • (2005) J. Clin. Oncol , vol.23 , pp. 1420-1430
    • Cristofanilli, M.1    Hayes, D.F.2    Budd, G.T.3    Ellis, M.J.4    Stopeck, A.5    Reuben, J.M.6
  • 3
    • 84878112286 scopus 로고    scopus 로고
    • Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials
    • Bidard F.-C., Fehm T., Ignatiadis M., Smerage J.B., Alix-Panabières C., Janni W., et al. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials. Cancer Metastasis Rev 2013, 32:179-188. 10.1007/s10555-012-9398-0.
    • (2013) Cancer Metastasis Rev , vol.32 , pp. 179-188
    • Bidard, F.-C.1    Fehm, T.2    Ignatiadis, M.3    Smerage, J.B.4    Alix-Panabières, C.5    Janni, W.6
  • 4
    • 84903289929 scopus 로고    scopus 로고
    • Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500
    • Smerage J.B., Barlow W.E., Hortobagyi G.N., Winer E.P., Leyland-Jones B., Srkalovic G., et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J. Clin. Oncol 2014, 32:3483-3489. 10.1200/JCO.2014.56.2561.
    • (2014) J. Clin. Oncol , vol.32 , pp. 3483-3489
    • Smerage, J.B.1    Barlow, W.E.2    Hortobagyi, G.N.3    Winer, E.P.4    Leyland-Jones, B.5    Srkalovic, G.6
  • 5
    • 57849117384 scopus 로고    scopus 로고
    • New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
    • Eisenhauer E.A., Therasse P., Bogaerts J., Schwartz L.H., Sargent D., Ford R., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur. J. Cancer 2009, 45:228-247. 10.1016/j.ejca.2008.10.026.
    • (2009) Eur. J. Cancer , vol.45 , pp. 228-247
    • Eisenhauer, E.A.1    Therasse, P.2    Bogaerts, J.3    Schwartz, L.H.4    Sargent, D.5    Ford, R.6
  • 6
    • 6044259206 scopus 로고    scopus 로고
    • Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    • Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res 2004, 10:6897-6904. 10.1158/1078-0432.CCR-04-0378.
    • (2004) Clin. Cancer Res , vol.10 , pp. 6897-6904
    • Allard, W.J.1    Matera, J.2    Miller, M.C.3    Repollet, M.4    Connelly, M.C.5    Rao, C.6
  • 7
    • 0021947525 scopus 로고
    • A prognostic inflammatory and nutritional index scoring critically ill patients
    • Ingenbleek Y., Carpentier Y.A. A prognostic inflammatory and nutritional index scoring critically ill patients. Int. J. Vitam. Nutr. Res 1985, 55:91-101.
    • (1985) Int. J. Vitam. Nutr. Res , vol.55 , pp. 91-101
    • Ingenbleek, Y.1    Carpentier, Y.A.2
  • 8
    • 0038576290 scopus 로고    scopus 로고
    • Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index
    • Walsh D., Mahmoud F., Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support. Care Cancer 2003, 11:60-62. 10.1007/s00520-002-0390-z.
    • (2003) Support. Care Cancer , vol.11 , pp. 60-62
    • Walsh, D.1    Mahmoud, F.2    Barna, B.3
  • 9
    • 0037412160 scopus 로고    scopus 로고
    • The cancer anorexia-cachexia syndrome: a survey of the Prognostic Inflammatory and Nutritional Index (PINI) in advanced disease
    • Nelson K.A., Walsh D. The cancer anorexia-cachexia syndrome: a survey of the Prognostic Inflammatory and Nutritional Index (PINI) in advanced disease. J. Pain Symptom Manage 2002, 24:424-428.
    • (2002) J. Pain Symptom Manage , vol.24 , pp. 424-428
    • Nelson, K.A.1    Walsh, D.2
  • 10
    • 45149093742 scopus 로고    scopus 로고
    • Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors
    • Barbot A.-C., Mussault P., Ingrand P., Tourani J.-M. Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. J. Clin. Oncol 2008, 26:2538-2543. 10.1200/JCO.2007.14.9518.
    • (2008) J. Clin. Oncol , vol.26 , pp. 2538-2543
    • Barbot, A.-C.1    Mussault, P.2    Ingrand, P.3    Tourani, J.-M.4
  • 11
    • 43049110616 scopus 로고    scopus 로고
    • Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications
    • Nolé F., Munzone E., Zorzino L., Minchella I., Salvatici M., Botteri E., et al. Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann. Oncol 2008, 19:891-897. 10.1093/annonc/mdm558.
    • (2008) Ann. Oncol , vol.19 , pp. 891-897
    • Nolé, F.1    Munzone, E.2    Zorzino, L.3    Minchella, I.4    Salvatici, M.5    Botteri, E.6
  • 12
    • 70449713638 scopus 로고    scopus 로고
    • Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer
    • Liu M.C., Shields P.G., Warren R.D., Cohen P., Wilkinson M., Ottaviano Y.L., et al. Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J. Clin. Oncol 2009, 27:5153-5159. 10.1200/JCO.2008.20.6664.
    • (2009) J. Clin. Oncol , vol.27 , pp. 5153-5159
    • Liu, M.C.1    Shields, P.G.2    Warren, R.D.3    Cohen, P.4    Wilkinson, M.5    Ottaviano, Y.L.6
  • 13
    • 77956132705 scopus 로고    scopus 로고
    • Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy
    • Bidard F.-C., Mathiot C., Degeorges A., Etienne-Grimaldi M.-C., Delva R., Pivot X., et al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann. Oncol 2010, 21:1765-1771. 10.1093/annonc/mdq052.
    • (2010) Ann. Oncol , vol.21 , pp. 1765-1771
    • Bidard, F.-C.1    Mathiot, C.2    Degeorges, A.3    Etienne-Grimaldi, M.-C.4    Delva, R.5    Pivot, X.6
  • 14
    • 84897445481 scopus 로고    scopus 로고
    • Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
    • Bidard F.-C., Peeters D.J., Fehm T., Nolé F., Gisbert-Criado R., Mavroudis D., et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014, 15:406-414. 10.1016/S1470-2045(14)70069-5.
    • (2014) Lancet Oncol , vol.15 , pp. 406-414
    • Bidard, F.-C.1    Peeters, D.J.2    Fehm, T.3    Nolé, F.4    Gisbert-Criado, R.5    Mavroudis, D.6
  • 15
    • 84857613654 scopus 로고    scopus 로고
    • High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients
    • Pierga J.-Y., Hajage D., Bachelot T., Delaloge S., Brain E., Campone M., et al. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann. Oncol 2012, 23:618-624. 10.1093/annonc/mdr263.
    • (2012) Ann. Oncol , vol.23 , pp. 618-624
    • Pierga, J.-Y.1    Hajage, D.2    Bachelot, T.3    Delaloge, S.4    Brain, E.5    Campone, M.6
  • 16
    • 58949088650 scopus 로고    scopus 로고
    • Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
    • Olmos D., Arkenau H.-T., Ang J.E., Ledaki I., Attard G., Carden C.P., et al. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann. Oncol 2009, 20:27-33. 10.1093/annonc/mdn544.
    • (2009) Ann. Oncol , vol.20 , pp. 27-33
    • Olmos, D.1    Arkenau, H.-T.2    Ang, J.E.3    Ledaki, I.4    Attard, G.5    Carden, C.P.6
  • 17
    • 84874651590 scopus 로고    scopus 로고
    • Translating metastasis-related biomarkers to the clinic - progress and pitfalls
    • Bidard F.C., Pierga J.-Y., Soria J.-C., Thiery J.P. Translating metastasis-related biomarkers to the clinic - progress and pitfalls. Nat. Rev. Clin. Oncol 2013, 10:169-179. 10.1038/nrclinonc.2013.4.
    • (2013) Nat. Rev. Clin. Oncol , vol.10 , pp. 169-179
    • Bidard, F.C.1    Pierga, J.-Y.2    Soria, J.-C.3    Thiery, J.P.4
  • 18
    • 84903289929 scopus 로고    scopus 로고
    • Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500
    • Smerage J.B., Barlow W.E., Hortobagyi G.N., et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J. Clin. Oncol 2014, 32:3483-3489. 10.1200/JCO.2014.56.2561.
    • (2014) J. Clin. Oncol , vol.32 , pp. 3483-3489
    • Smerage, J.B.1    Barlow, W.E.2    Hortobagyi, G.N.3
  • 19
    • 84906058293 scopus 로고    scopus 로고
    • Differential drug responses of circulating tumor cells within patient blood
    • Hughes A.D., Marshall J.R., Keller E., et al. Differential drug responses of circulating tumor cells within patient blood. Cancer Lett 2014, 352(1):28-35. 10.1016/j.canlet.2013.08.026.
    • (2014) Cancer Lett , vol.352 , Issue.1 , pp. 28-35
    • Hughes, A.D.1    Marshall, J.R.2    Keller, E.3
  • 20
    • 84886379960 scopus 로고    scopus 로고
    • Going with the flow: from circulating tumor cells to DNA
    • 207ps14
    • Bidard F.C., Weigelt B., Reis-Filho J.S. Going with the flow: from circulating tumor cells to DNA. Sci. Transl. Med 2013, 5. 207ps14. 10.1126/scitranslmed.3006305.
    • (2013) Sci. Transl. Med , vol.5
    • Bidard, F.C.1    Weigelt, B.2    Reis-Filho, J.S.3
  • 21
    • 84923164411 scopus 로고    scopus 로고
    • Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients
    • Madic J., Kiialainen A., Bidard F.C., et al. Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients. Int. J. Cancer 2014, 10.1002/ijc.29265.
    • (2014) Int. J. Cancer
    • Madic, J.1    Kiialainen, A.2    Bidard, F.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.